Correction: A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

Sabuj Kanti Das; Snehasis Mishra; Krishnendu Manna; Utpal Kayal; Supratim Mahapatra; Krishna Das Saha; Sasanka Dalapati; G. P. Das; Amany A. Mostafa; Asim Bhaumik

doi:10.1039/C8CC90465K

Correction: A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

Sabuj Kanti Das,^a Snehasis Mishra,^b Krishnendu Manna,^b Utpal Kayal,^a Supratim Mahapatra,^b Krishna Das Saha,^b Sasanka Dalapati,^c G. P. Das,^a Amany A. Mostafa^d and Asim Bhaumik*^a

Author affiliations

* Corresponding authors

^a Department of Materials Science, Indian Association for the Cultivation of Science Jadavpur, Kolkata – 700 032, India
E-mail: msab@iacs.res.in

^b Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Jadavpur, Kolkata – 700032, India

^c Department of Chemistry, Indian Institute of Engineering Science and Technology, Shibpur, Howrah – 711103, India

^d Department of Ceramic, Nanomedicine & Tissue Engineering Laboratory, National Research Centre, El Bohouth St., Dokki, Cairo – 12622, Egypt

Abstract

Correction for ‘A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities’ by Sabuj Kanti Das et al., Chem. Commun., 2018, 54, 11475–11478.

Chemical Communications

Correction: A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

Social activity

Search articles by author

Spotlight

Advertisements